Oct 30, 2021 08:00 AM

Chongqing Zhifei Biological Products Co.,Ltd.’s Net Profit Rose 239% in First Three Quarters of 2021

Chongqing Zhifei Biological Products Co.,Ltd. (重庆智飞生物制品股份有限公司) (300122.SZ) reported a net profit of 8.4 billion yuan in the first three quarters of 2021, up 239% year-on-year.

Meanwhile, the company posted 21.8 billion yuan in revenue, up 97.5% year-on-year.

At the end of the reporting period, it had 27.2 billion yuan in total assets and 11.4 billion yuan in total liabilities, with a liability-to-asset ratio of 41.8%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
Caixin-Sinica Business Brief: TikTok CEO Pushes Back on Security Concerns